Crescent Biopharma (CBIO) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,223.16% |
| Dec 31, 2025 | 574.66% |
| Sep 30, 2025 | 780.80% |
| Jun 30, 2025 | 544.72% |
| Mar 31, 2025 | -82.48% |
| Dec 31, 2024 | -21.40% |
| Sep 30, 2024 | -70.49% |
| Jun 30, 2024 | -60.50% |
| Mar 31, 2024 | -50.37% |
| Dec 31, 2023 | -12.53% |
| Sep 30, 2023 | -4.93% |
| Jun 30, 2023 | -4.95% |
| Mar 31, 2023 | -15.40% |
| Dec 31, 2022 | -45.08% |
| Sep 30, 2022 | -48.16% |
| Jun 30, 2022 | -47.70% |
| Mar 31, 2022 | -40.98% |
| Dec 31, 2021 | -33.95% |
| Sep 30, 2021 | -28.24% |
| Jun 30, 2021 | -21.45% |
| Mar 31, 2021 | -14.85% |
| Dec 31, 2020 | -14.97% |
| Sep 30, 2020 | -16.64% |
| Jun 30, 2020 | -17.67% |
| Mar 31, 2020 | -20.71% |
| Dec 31, 2019 | -21.82% |
| Sep 30, 2019 | -19.86% |
| Jun 30, 2019 | -18.40% |
| Mar 31, 2019 | -17.37% |
| Dec 31, 2018 | 67.08% |
| Sep 30, 2018 | 94.41% |
| Jun 30, 2018 | 93.79% |
| Mar 31, 2018 | 565.57% |
| Dec 31, 2017 | 203.35% |
| Sep 30, 2017 | 141.24% |
| Jun 30, 2017 | 118.07% |
| Mar 31, 2017 | -8.67% |
| Dec 31, 2016 | -12.53% |
| Sep 30, 2016 | -13.87% |
| Jun 30, 2016 | -10.11% |
| Mar 31, 2016 | -16.01% |
| Dec 31, 2015 | -15.37% |
| Sep 30, 2015 | -10.72% |
| Jun 30, 2015 | -8.11% |
| Mar 31, 2015 | -16.54% |
| Dec 31, 2014 | 983.83% |